Tan Kevin, CFO and Treasurer of Solid Biosciences Inc. ($SLDB), sold common shares on the open market four times in the last 365 days, totaling about $330,000. His most recent sale occurred on February 18, 2026. These sales rank 7,369th among 11,678 individual insiders, below the average of $8.6 million per person and 6.4 transactions. Tan Kevin made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 10625 | $0.00 | 104,826.0000 | 94,417,746 | 11.28% | 0.01% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 10625 | $0.00 | 21,250.0000 | 94,417,746 | 33.33% | 0.01% |
| Feb. 18, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 5404 | $5.82 | 99,422.0000 | 94,417,746 | 5.16% | 0.01% |
| Feb. 4, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 14783 | $6.44 | 94,201.0000 | 94,417,746 | 13.56% | 0.02% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Performance Stock Units | 56646 | $0.00 | 0.0000 | 94,417,746 | 100.00% | 0.06% |
| Feb. 2, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 26837 | $6.44 | 108,984.0000 | 94,417,746 | 19.76% | 0.03% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 56646 | $0.00 | 102,746.0000 | 94,417,746 | 122.88% | 0.06% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 33075 | $0.00 | 135,821.0000 | 94,417,746 | 32.19% | 0.04% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 33075 | $0.00 | 99,225.0000 | 94,417,746 | 25.00% | 0.04% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Restricted Stock Units | 93500 | $0.00 | 93,500.0000 | 94,417,746 | 9999.99% | 0.10% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Employee Stock Option (Right to Buy) | 187000 | $0.00 | 187,000.0000 | 94,417,746 | 9999.99% | 0.20% |
| Jan. 9, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 11250 | $0.00 | 51,804.0000 | 94,417,746 | 27.74% | 0.01% |
| Jan. 13, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 5704 | $5.27 | 46,100.0000 | 94,417,746 | 11.01% | 0.01% |
| Jan. 9, 2026 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 11250 | $0.00 | 11,250.0000 | 94,417,746 | 50.00% | 0.01% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 40,816,694 | 9999.99% | 0.31% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Restricted Stock Units | 62500 | $0.00 | 62,500.0000 | 40,816,694 | 9999.99% | 0.15% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 10625 | $0.00 | 35,414.0000 | 40,816,694 | 42.86% | 0.03% |
| Feb. 14, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 3164 | $3.96 | 32,250.0000 | 40,816,694 | 8.93% | 0.01% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 10625 | $0.00 | 31,875.0000 | 40,816,694 | 25.00% | 0.03% |
| Jan. 31, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Restricted Stock Units | 132300 | $0.00 | 132,300.0000 | 40,816,694 | 9999.99% | 0.32% |
| Jan. 10, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 4073 | $3.89 | 24,789.0000 | 40,816,694 | 14.11% | 0.01% |
| Jan. 9, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 11250 | $0.00 | 22,500.0000 | 40,816,694 | 33.33% | 0.03% |
| Jan. 9, 2025 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 11250 | $0.00 | 28,862.0000 | 40,816,694 | 63.88% | 0.03% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Employee Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 19,884,007 | 9999.99% | 0.43% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | A | Restricted Stock Units | 42500 | $0.00 | 42,500.0000 | 19,884,007 | 9999.99% | 0.21% |
| Jan. 9, 2024 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Common Stock | 11250 | $0.00 | 13,243.0000 | 19,884,007 | 564.48% | 0.06% |
| Jan. 9, 2024 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | S | Common Stock | 3935 | $8.20 | 9,308.0000 | 19,884,007 | 29.71% | 0.02% |
| Jan. 9, 2024 | Solid Biosciences Inc. | $SLDB | Tan Kevin | CFO & Treasurer | M | Restricted Stock Units | 11250 | $0.00 | 33,750.0000 | 19,884,007 | 25.00% | 0.06% |